HRP20110076T1 - Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol - Google Patents

Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol Download PDF

Info

Publication number
HRP20110076T1
HRP20110076T1 HR20110076T HRP20110076T HRP20110076T1 HR P20110076 T1 HRP20110076 T1 HR P20110076T1 HR 20110076 T HR20110076 T HR 20110076T HR P20110076 T HRP20110076 T HR P20110076T HR P20110076 T1 HRP20110076 T1 HR P20110076T1
Authority
HR
Croatia
Prior art keywords
pain
dimethylamino
phenol
propyl
ethyl
Prior art date
Application number
HR20110076T
Other languages
English (en)
Croatian (hr)
Inventor
Bloms-Funke Petra
Schiene Klaus
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110076(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20110076T1 publication Critical patent/HRP20110076T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20110076T 2006-04-28 2007-04-25 Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol HRP20110076T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008851 2006-04-28
PCT/EP2007/003632 WO2007128413A1 (en) 2006-04-28 2007-04-25 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (1)

Publication Number Publication Date
HRP20110076T1 true HRP20110076T1 (hr) 2011-02-28

Family

ID=37025148

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110076T HRP20110076T1 (hr) 2006-04-28 2007-04-25 Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol

Country Status (24)

Country Link
EP (1) EP2012764B1 (pt)
JP (2) JP5496653B2 (pt)
KR (1) KR101396166B1 (pt)
CN (1) CN101431990B (pt)
AT (1) ATE494889T1 (pt)
AU (1) AU2007247481B2 (pt)
BR (1) BRPI0710682B8 (pt)
CA (1) CA2650423C (pt)
CY (1) CY1111369T1 (pt)
DE (1) DE602007011913D1 (pt)
DK (1) DK2012764T3 (pt)
EC (2) ECSP088793A (pt)
ES (1) ES2356093T3 (pt)
HR (1) HRP20110076T1 (pt)
IL (1) IL194883A (pt)
MX (1) MX2008013779A (pt)
NO (2) NO341602B1 (pt)
NZ (1) NZ571442A (pt)
PL (1) PL2012764T3 (pt)
PT (1) PT2012764E (pt)
RU (1) RU2442576C2 (pt)
SI (1) SI2012764T1 (pt)
WO (1) WO2007128413A1 (pt)
ZA (1) ZA200810124B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012165A1 (de) * 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
RS55769B1 (sr) * 2007-11-23 2017-07-31 Gruenenthal Gmbh Kompozicije tapentadola
EP2992877A1 (en) 2010-06-15 2016-03-09 Grünenthal GmbH Pharmaceutical combination for the treatment of pain
ES2910085T3 (es) 2011-03-04 2022-05-11 Gruenenthal Gmbh Composición farmacéutica acuosa semisólida que contiene tapentadol
MX388963B (es) 2011-03-04 2025-03-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral
CN103501775A (zh) 2011-03-04 2014-01-08 格吕伦塔尔有限公司 他喷他多的胃肠外给药
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
PE20171651A1 (es) 2015-03-27 2017-11-13 Gruenenthal Chemie Formulacion estable para administracion parenteral de tapentadol
EP3515412B1 (en) 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
EP3585370A1 (en) 2017-02-23 2020-01-01 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DK3241550T3 (da) * 2002-11-22 2020-08-24 Gruenenthal Gmbh Anvendelse af (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol til behandling af inflammatoriske smerter

Also Published As

Publication number Publication date
BRPI0710682A2 (pt) 2011-08-23
PT2012764E (pt) 2011-02-02
CY1111369T1 (el) 2015-08-05
ECSP17000643A (es) 2018-06-30
AU2007247481A1 (en) 2007-11-15
NO343505B1 (no) 2019-03-25
CN101431990B (zh) 2011-08-03
BRPI0710682B8 (pt) 2021-05-25
MX2008013779A (es) 2008-11-14
RU2008146816A (ru) 2010-06-10
PL2012764T3 (pl) 2011-04-29
SI2012764T1 (sl) 2011-03-31
NO20084542L (no) 2008-10-28
CA2650423A1 (en) 2007-11-15
WO2007128413A1 (en) 2007-11-15
RU2442576C2 (ru) 2012-02-20
EP2012764A1 (en) 2009-01-14
JP5496653B2 (ja) 2014-05-21
JP2013213045A (ja) 2013-10-17
KR101396166B1 (ko) 2014-05-27
NZ571442A (en) 2011-09-30
NO341602B1 (no) 2017-12-11
NO20171831A1 (no) 2008-10-28
BRPI0710682B1 (pt) 2020-09-24
CA2650423C (en) 2014-08-12
ZA200810124B (en) 2009-08-26
ATE494889T1 (de) 2011-01-15
KR20090006219A (ko) 2009-01-14
HK1127289A1 (en) 2009-09-25
ECSP088793A (es) 2008-11-27
JP2009535313A (ja) 2009-10-01
IL194883A0 (en) 2009-08-03
DE602007011913D1 (de) 2011-02-24
IL194883A (en) 2012-10-31
ES2356093T3 (es) 2011-04-04
DK2012764T3 (da) 2011-02-28
EP2012764B1 (en) 2011-01-12
CN101431990A (zh) 2009-05-13
AU2007247481B2 (en) 2013-02-14

Similar Documents

Publication Publication Date Title
HRP20110076T1 (hr) Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol
HRP20190500T1 (hr) Farmaceutska kombinacija 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola i pregabalina ili gabapentina
HRP20110271T1 (hr) Farmaceutska kombinacija koja sadrži 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i nsaid (nesteroidni antiinflamatorni lijek)
HRP20151327T1 (hr) Farmaceutska kombinacija za lijeäśenje boli
JP2023098949A (ja) 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター
HRP20120866T1 (hr) Makrocikliäśni spojevi hinoksalina kao inhibitori hcv ns3 proteaze
JP2007533686A5 (pt)
ES3055488T3 (en) Tegavivint for use in the treatment of pulmonary fibrosis
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
RU2013121788A (ru) Ингибиторы репликации вич
JP2009504763A5 (pt)
EP2275107A3 (en) Combinations for the treatment of diseases involving cell proliferation
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
ES3029560T3 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione as glucocorticoid-sparing agent
HRP20140215T1 (hr) Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika
RU2349323C2 (ru) Комбинация избирательного ингибитора обратного захвата норадреналина и ингибитора pdev
MX2009002311A (es) Composiciones farmaceuticas para tratamiento de infecciones fungales.
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
JP2020533402A5 (pt)
JP2009520010A5 (pt)
MX2024002892A (es) Azalidos inmunomoduladores.
JP2009538822A (ja) 静脈におけるウイルスの治療
JP2009533428A (ja) 筋肉内抗ウイルス処置
RU2010151433A (ru) Терапевтическое средство против боли
HRP20110225T1 (hr) Nova kombinacija lijekova kao antidepresivi